| Financial Year |
March 31 2023 |
| Monetary Funds |
3,458,643,607.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,859,786,254.48 |
| Advances to Suppliers |
180,194,734.81 |
| Other Receivables |
303,656,258.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,753,438,552.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
147,452,048.71 |
| Total Current Assets |
8,751,326,180.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
397,205,900.99 |
| Investment Properties |
19,155,759.99 |
| Fixed Assetes |
3,765,300,714.41 |
| Under-construction Projects |
621,714,010.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
203,348,572.05 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
136,883,721.27 |
| R&D expenses |
-- |
| Goodwill |
109,504,584.20 |
| Long-Term Deferred and Prepaid Expenses |
152,099,377.21 |
| Deferred Income Tax Assets |
42,698,732.31 |
| Other Non-Current Assets |
114,850,072.95 |
| Sub-Total of Non-Current Assets |
5,996,277,826.32 |
| Total Assets |
14,747,604,006.47 |
| Short-Term Loans |
1,947,601,421.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,782,280,616.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
300,696,212.69 |
| Taxes Payable |
139,077,717.77 |
| Interest Payable |
6,725,058.73 |
| Dividend Payable |
71,050,000.00 |
| Other payables |
1,437,838,060.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
328,970,240.17 |
| Other Current Liabilities |
50,493,620.49 |
| Sub-Total of Current Liabilities |
6,476,343,578.14 |
| Long-term Loans |
768,180,719.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,723,733.87 |
| Special Payable |
-- |
| Estimatied Liabilities |
29,149,535.20 |
| Deferred Income Tax Liabilities |
45,322,542.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,279,992,874.49 |
| Total Liabilities |
7,756,336,452.63 |
| Paid-In Capital(Or Share Stock) |
937,729,472.00 |
| Capital Surplus |
1,816,127,679.89 |
| Surplus Reserve |
226,207,013.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,176,224,105.16 |
| Minority Stockholder's Interest |
2,108,761,479.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,882,506,074.30 |
| Owner's Equity（Stockholder's Equity） |
6,991,267,553.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,747,604,006.47 |
